Atropos compares how well leading LLMs generate clinical evidence
Fierce Healthcare
JULY 15, 2024
A new study released by healthcare AI company Atropos found that general purpose LLMs like ChatGPT, Claude and Gemini are not fit for use in clinical decisionmaking. | Healthcare AI company Atropos conducted a study to test how reliably ChatGPT, Claude, Gemini, OpenEvidence and its own model, ChatRWD, answer clinicians' questions. General use LLMs did not fare well.
Let's personalize your content